Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 2b/3, Adaptive, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

The Sponsor is studying an investigational medication called danicamtiv to determine if it can help people with genetic and familial dilated cardiomyopathy (DC…

Symptomatic Genetic Dilated Cardiomyopathy

Kardigan, Inc.NCT07210723